Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Lyndon Luk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4468-3128; OpenAlex author ID A5032193214. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Routine CT reporting of vascular involvement in pancreatic ductal adenocarcinoma: completeness and association with margin-positive resection. Co-author DOI 10.1007/s00261-026-05815-4↗
  2. Invited Commentary: Pancreatic Cancer Screening and Early Detection: Current Perspectives and Future Opportunity Co-author DOI 10.1148/rg.250255↗
  3. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Di… Co-author DOI 10.2214/ajr.24.32160↗
  4. A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. Co-author DOI 10.1093/oncolo/oyad315↗
  5. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs. Co-author DOI 10.2214/ajr.24.31151↗
  6. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
  7. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consor… Co-author DOI 10.2214/ajr.22.27859↗
  8. Imaging of pancreatic cancer: what the surgeon wants to know. Co-author DOI 10.1016/j.clinimag.2016.10.002↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenchan Huang · 4 shared papers, 2022–2026 · strength 0.78
  2. Elizabeth M. Hecht · 5 shared papers, 2017–2025 · strength 0.70
  3. Milana Flusberg · 1 shared paper, 2026 · strength 0.63
  4. Avinash R. Kambadakone · 4 shared papers, 2022–2025 · strength 0.61
  5. Michael D. Kluger · 3 shared papers, 2017–2026 · strength 0.56
  6. Joy Liau · 3 shared papers, 2022–2025 · strength 0.48
  7. Samuel Joseph Galgano · 3 shared papers, 2023–2025 · strength 0.47
  8. Erik V. Soloff · 3 shared papers, 2023–2025 · strength 0.47
  9. Michael Hayden Rosenthal · 2 shared papers, 2023–2024 · strength 0.30
  10. Ott Le · 2 shared papers, 2023–2024 · strength 0.30
  11. Naveen M. Kulkarni · 2 shared papers, 2023–2024 · strength 0.30
  12. Priya Bhosale · 2 shared papers, 2023–2024 · strength 0.30
  13. Ajit Harishkumar Goenka · 2 shared papers, 2023–2024 · strength 0.30
  14. Jehan Bista · 1 shared paper, 2026 · strength 0.30
  15. Zhen J. Wang · 2 shared papers, 2023–2025 · strength 0.29
  16. Marc Zins · 2 shared papers, 2023–2025 · strength 0.29
  17. Jin Peng He · 2 shared papers, 2023–2025 · strength 0.29
  18. Candice W. Bolan · 2 shared papers, 2023–2025 · strength 0.29
  19. Atif Zaheer · 2 shared papers, 2023–2025 · strength 0.29
  20. Richard Kinh Gian · 2 shared papers, 2023–2025 · strength 0.29
  21. Linda Chi Hang Chu · 2 shared papers, 2023–2025 · strength 0.29
  22. Alexander Savio Ramos Guimaraes · 2 shared papers, 2022–2023 · strength 0.26
  23. Michael S. May · 1 shared paper, 2024 · strength 0.24
  24. Alexander Grenander Raufi · 1 shared paper, 2024 · strength 0.24
  25. Jacob K.R. Jamison · 1 shared paper, 2024 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.